2016 Digestive Disease Week

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Samir Gupta, MD, Associate Professor of Medicine at the University of California San Diego, who has led trials of colorectal cancer screening, commented on this study for The ASCO Post. Although the...

Colorectal Cancer

Caroline Helwick / June 25, 2016 / 2016 Digestive Disease Week

Young-Onset Colorectal Cancer Diagnoses Rising

Colorectal cancer is being increasingly diagnosed in persons younger than age 50, the age at which colorectal cancer screening is usually initiated. According to Elie Sutton, MD, of Mount Sinai West...

Feb

Today In Oncology

CMS Proposes Medicare Coverage With Evidence Development for CAR T-Cell Therapy

FDA Pipeline: Priority Reviews in Renal Cell Carcinoma and Head and Neck Cancer

First-Line Pembrolizumab in Advanced Merkel Cell Carcinoma

Gastric Acid Suppressants May Reduce Survival Outcomes in Patients With Sarcoma Treated With Pazopanib

New Approach to Predicting Response to Pertuzumab and Trastuzumab in Breast Cancer

;

2016 Digestive Disease Week

Expert Point of View: Samir Gupta, MD

Young-Onset Colorectal Cancer Diagnoses Rising

CMS Proposes Medicare Coverage With Evidence Development for CAR T-Cell Therapy

FDA Pipeline: Priority Reviews in Renal Cell Carcinoma and Head and Neck Cancer

First-Line Pembrolizumab in Advanced Merkel Cell Carcinoma

Gastric Acid Suppressants May Reduce Survival Outcomes in Patients With Sarcoma Treated With Pazopanib

New Approach to Predicting Response to Pertuzumab and Trastuzumab in Breast Cancer

SABCS 2018: Delayed Initiation of Adjuvant Chemotherapy Associated With Worse Outcomes in Patients With Triple-Negative Breast Cancer

Power of Pathologic Complete Response to Neoadjuvant Therapy Demonstrated in I-SPY 2 Trial

2019 GU Cancers Symposium: KEYNOTE-426: Pembrolizumab Plus Axitinib vs Sunitinib in Advanced Renal Cell Carcinoma

Novel Treatments of Myelodysplastic Syndromes

Selected Abstracts From the San Antonio Breast Cancer Symposium

Kieron M. Dunleavy, MD, on B-Cell Malignancies: Novel-Novel Drug Combinations

Jonathan W. Friedberg, MD, on Follicular Lymphoma: Novel Combination Therapies

Jonathan R. Strosberg, MD, on Neuroendocrine Tumors: Results From the KEYNOTE-158 Trial on PD-1 Inhibition

Eva M. Ciruelos, MD, PhD, on HER2-Positive Breast Cancer: Results From the PATRICIA Trial

Susan Blumel, RN, BSN, and Laura J. Zitella, MS, RN, ACNP-BC, AOCN, on Managing Toxicities of Immunotherapy